How to Get Vardenafil (Levitra/Staxyn) in New Jersey

What Is Vardenafil and How Does It Work?

Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA in 2003 for erectile dysfunction. It blocks PDE5 in the corpus cavernosum, allowing cyclic guanosine monophosphate (cGMP) to accumulate and smooth muscle to relax, which increases penile blood flow during sexual stimulation. The drug does not cause erection without arousal.

Two formulations exist. Levitra is a standard film-coated tablet available in 2.5 mg, 5 mg, 10 mg, and 20 mg strengths. Staxyn is a 10 mg orally disintegrating tablet (ODT) that dissolves on the tongue without water. The ODT uses a different bioavailability profile than the film-coated tablet, so the two are not interchangeable milligram-for-milligram.

In a key trial by Porst et al. (2003, N=580), vardenafil 20 mg improved the International Index of Erectile Function (IIEF) erectile-function domain score by 9.0 points over baseline compared to 3.7 points for placebo. Success rates for vaginal penetration reached 80% in the vardenafil group versus 49% in the placebo group. The effect size is comparable to sildenafil and tadalafil, though head-to-head trials show modest pharmacokinetic differences rather than clear superiority for any single PDE5 inhibitor (Rosen et al., J Urol, 2004).

Prescribing Rules for Vardenafil in New Jersey

New Jersey permits licensed physicians (MDs and DOs), nurse practitioners, and physician assistants to prescribe vardenafil. NPs in New Jersey gained full independent prescriptive authority under P.L. 2018, c.57, meaning they can evaluate, diagnose ED, and prescribe PDE5 inhibitors without a collaborating physician. PAs prescribe under a collaborative agreement with a supervising physician, per the New Jersey State Board of Medical Examiners.

A prescriber will typically assess cardiovascular fitness before starting any PDE5 inhibitor. The American Urological Association (AUA) guidelines recommend a focused history, physical exam (including genital and cardiovascular exam), and baseline labs. The minimum lab panel before vardenafil includes a fasting glucose or HbA1c, a lipid panel, and total testosterone. Some prescribers also order a complete metabolic panel and thyroid-stimulating hormone (TSH). These labs serve two purposes: they rule out reversible causes of ED (hypogonadism, diabetes) and they confirm no contraindications to PDE5 inhibitor use.

Vardenafil is contraindicated in patients taking nitrates in any form. It is also contraindicated with potent CYP3A4 inhibitors like ritonavir and with alpha-blockers unless the patient is stable on a low alpha-blocker dose. Men with a resting QTc interval exceeding 500 ms or those on Class IA or Class III antiarrhythmics should not take vardenafil per the FDA prescribing information.

How Telehealth Works for Vardenafil in New Jersey

New Jersey is one of the most telehealth-permissive states in the country. The state adopted permanent telehealth legislation in 2020 (P.L. 2020, c.3), which authorizes prescribing controlled and non-controlled medications via audio-video telemedicine encounters. Vardenafil is not a controlled substance, so prescribing it via telehealth in NJ carries no schedule-related restrictions.

A typical telehealth visit for vardenafil follows this workflow: the patient completes a medical intake questionnaire, uploads recent lab work (or orders labs through the platform), and then meets with a licensed NJ prescriber via synchronous video. The prescriber reviews the history, confirms cardiovascular safety, discusses dosing, and sends the prescription electronically to a pharmacy of the patient's choice.

Multiple telehealth platforms operate in New Jersey for ED prescribing, including HealthRX. The key regulatory requirement is that the prescriber holds an active New Jersey medical license. Out-of-state telehealth prescribers cannot write NJ prescriptions unless they also hold an NJ license or qualify under the state's temporary telemedicine permit provisions. Patients should verify their provider's NJ license through the New Jersey Division of Consumer Affairs license verification portal.

Most telehealth consultations for ED take 10 to 20 minutes. If labs are current (within 12 months) and no contraindications exist, a prescription can be sent to the pharmacy the same day. Some platforms offer next-day delivery within New Jersey.

Pharmacy and Compounding Options in New Jersey

New Jersey residents have three dispensing pathways for vardenafil.

Retail pharmacies. Any licensed NJ pharmacy (CVS, Walgreens, Rite Aid, independent pharmacies) can fill a vardenafil prescription. Generic vardenafil tablets became available in 2018 after Bayer's patent expired. Cash prices for generic vardenafil range from $8 to $30 per tablet depending on dose and pharmacy, though discount programs can push the price below $3 per tablet at some retailers. Brand Levitra is rarely stocked and costs significantly more.

Mail-order pharmacies. National mail-order pharmacies licensed in NJ (Express Scripts, OptumRx, Amazon Pharmacy, Mark Cuban Cost Plus Drug Company) can ship vardenafil to NJ addresses. Cost Plus lists generic vardenafil 20 mg at $3.60 for a 30-count supply before shipping.

503A compounding pharmacies. New Jersey licenses 503A compounding pharmacies that can prepare custom vardenafil formulations (for example, sublingual troches or combination tablets with other agents). A 503A pharmacy fills prescriptions for individually identified patients based on a valid prescription. These pharmacies can ship within New Jersey. They cannot distribute compounded drugs without patient-specific prescriptions, per the FDA's guidance on 503A entities.

A 2022 analysis in the Journal of Sexual Medicine reported that PDE5 inhibitor costs decreased 40% to 70% after generic entry, making vardenafil more accessible than at any prior point since its 2003 approval.

Insurance and Medicaid Coverage in New Jersey

Private insurance plans in New Jersey vary widely in how they cover PDE5 inhibitors. Some plans cover generic vardenafil with a tier-2 or tier-3 copay. Others exclude ED medications entirely or limit coverage to 6 to 12 tablets per month. Prior authorization (PA) is common.

New Jersey Medicaid covers vardenafil with prior authorization. To obtain PA, the prescriber must document all of the following:

1. A confirmed diagnosis of erectile dysfunction (ICD-10 code N52.x).
2. A clinical evaluation including relevant labs.
3. That the medication is not being prescribed for cosmetic or recreational purposes.
4. That nitrate therapy is not concurrent.

PA turnaround through NJ FamilyCareMedicaid typically takes 24 to 72 hours. If denied, the prescriber can submit a formal appeal, and patients have the right to a fair hearing under NJ Medicaid regulations.

"Prior authorization for PDE5 inhibitors in state Medicaid programs generally requires documentation of organic ED etiology and cardiovascular safety screening," according to a 2019 review in the Journal of Managed Care & Specialty Pharmacy.

For patients without insurance, GoodRx and similar discount platforms frequently offer coupons that reduce generic vardenafil to $5 to $15 per tablet. The Bayer patient assistance program historically covered brand Levitra for qualifying uninsured patients, though brand availability has decreased as generic uptake grew.

Dosing, Timing, and What to Expect

The recommended starting dose is 10 mg taken 60 minutes before anticipated sexual activity. Based on efficacy and tolerability, the prescriber may adjust the dose to 5 mg or 20 mg. The maximum frequency is once per 24 hours. For the ODT formulation (Staxyn), the dose is fixed at 10 mg, and patients should not take it with liquid since the tablet is designed to dissolve on the tongue.

Onset occurs within 25 to 60 minutes for most men. A pharmacokinetic study showed that vardenafil reaches peak plasma concentration (Tmax) at approximately 0.7 to 0.9 hours. High-fat meals can delay absorption of the film-coated tablet by about 1 hour and reduce Cmax by 18% to 50%. The ODT formulation is less affected by food.

Duration of action is approximately 4 to 5 hours, shorter than tadalafil's 36-hour window but comparable to sildenafil. For men who want longer duration, daily low-dose tadalafil (2.5 mg or 5 mg) is an alternative, though vardenafil is not FDA-approved for daily dosing.

Special populations require dose adjustments. Men aged 65 and older should start at 5 mg. Patients with moderate hepatic impairment (Child-Pugh B) should not exceed 10 mg. Those taking moderate CYP3A4 inhibitors (erythromycin, ketoconazole at 200 mg daily) should cap at 5 mg per 24 hours.

Side Effects and Safety Profile

The most common adverse events in clinical trials were headache (15%), flushing (11%), rhinitis (9%), and dyspepsia (4%), based on pooled trial data submitted to the FDA. These effects are dose-dependent and typically mild to moderate.

Vardenafil has a unique cardiac consideration among PDE5 inhibitors: it can prolong the QTc interval by a mean of 8 ms at therapeutic doses and up to 10 ms at supratherapeutic doses (80 mg). This effect is small but clinically relevant for patients with congenital long QT syndrome or those on QT-prolonging medications. Neither sildenafil nor tadalafil shows this degree of QTc effect, so prescribers in NJ may favor those alternatives for patients with borderline QTc intervals.

Rare but serious adverse events include non-arteritic anterior ischemic optic neuropathy (NAION), sudden sensorineural hearing loss, and priapism (erection lasting more than 4 hours). A post-marketing surveillance study found the incidence of NAION across all PDE5 inhibitors to be approximately 2.8 cases per 100,000 patient-years of use.

"Patients with pre-existing cardiovascular risk factors should undergo a thorough evaluation before initiating PDE5 inhibitor therapy," per the Princeton III Consensus Panel recommendations published in the Journal of Sexual Medicine.

Vardenafil vs. Other PDE5 Inhibitors Available in NJ

New Jersey pharmacies stock all four FDA-approved PDE5 inhibitors. Here is how vardenafil compares on key clinical parameters:

Onset and duration. Vardenafil's onset (25 to 60 min) and duration (4 to 5 hours) are similar to sildenafil. Tadalafil lasts up to 36 hours and is approved for daily use. Avanafil (Stendra) has the fastest onset at 15 to 30 minutes but shorter clinical experience.

Food interaction. Vardenafil film-coated tablets are moderately affected by high-fat meals. Tadalafil is food-independent. Sildenafil is also affected by fatty food. The vardenafil ODT is less food-sensitive than the film-coated tablet.

Cost in NJ. Generic vardenafil, sildenafil, and tadalafil are all priced comparably at $3 to $15 per tablet through discount programs. Brand pricing is clinically irrelevant now that generics dominate the market.

QTc effect. Vardenafil is the only PDE5 inhibitor with a labeled QTc prolongation warning. For patients on antiarrhythmics, sildenafil or tadalafil may be preferred.

A network meta-analysis by Yuan et al. (2013) pooled 82 RCTs (N=47,626) and found no statistically significant difference in efficacy among the four PDE5 inhibitors. The choice between agents is driven by patient preference for dosing flexibility, onset speed, side-effect profile, and drug interactions rather than by raw efficacy differences.

Transferring a Prescription to New Jersey

Patients moving to New Jersey or visiting from another state can transfer an existing vardenafil prescription. Under New Jersey Board of Pharmacy regulations (N.J.A.C. 13:39), pharmacies accept prescription transfers from other states for non-controlled medications. The process requires the receiving NJ pharmacy to contact the originating pharmacy by phone or electronic transfer system. Vardenafil is not a controlled substance, so DEA transfer restrictions do not apply.

For telehealth patients, a simpler path may be to schedule a new consultation with an NJ-licensed prescriber. This avoids transfer delays and allows the new prescriber to confirm current labs and clinical status.